Trial of Aganirsen in iCRVO Patients at Risk of Developing NVG

Clinical trial NCT02947867 · UNKNOWN

Trial details

NCT number: NCT02947867
Sponsor: Gene Signal SAS
Status: UNKNOWN
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Ischaemic Central Retinal Vein Occlusion Neovascular Glaucoma

Start date: 2017-01-01
Primary completion: 2019-06-01
Enrollment: 333

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.